Frontlight ResearchEarly access
Triple-negative breast cancer trials in United States
14 of 172 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleCollection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 139
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07619534 - No phaseEnrolling by invitationA Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
- Where
- Gilbert, La Jolla, Los Angeles, New York, Rochester
- Age
- 18 years and over
- People
- 400
- Run by
- A2 Biotherapeutics Inc.
See details and how to joinNCT06885424 - No phaseTaking peopleProspective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Where
- Durham, San Francisco, The Bronx
- Age
- 18 years and over
- People
- 100
- Run by
- University of California, San Francisco
See details and how to joinNCT06774027 - No phaseTaking peopleEvaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Where
- Ann Arbor, Birmingham, Carbondale, Cincinnati, Florham Park, Goshen, Houston, La Crosse, Nashville, O'Fallon, Reno, Sioux Falls, Spokane Valley, Springfield, Weston, Whittier
- Age
- 18 years to 99 years
- People
- 900
- Run by
- Tempus AI
See details and how to joinNCT07211178 - No phaseTaking peopleTriple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
- Where
- Hays, Kansas City, Lee's Summit, Overland Park, Salina, Westwood
- People
- 3,000
- Run by
- University of Kansas Medical Center
See details and how to joinNCT02302742 - No phaseTaking peoplePredicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Where
- Forth Worth, Fort Smith, Frederick, Oklahoma City, Springfield, St Louis, Temple
- Age
- 18 years and over
- People
- 2,000
- Run by
- Elephas
See details and how to joinNCT07327489 - No phaseTaking peopleEvaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
- Where
- Atlanta
- Age
- 18 years and over
- People
- 10
- Run by
- Emory University
See details and how to joinNCT05877859 - No phaseTaking peoplectDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 77
- Run by
- University of Pittsburgh
See details and how to joinNCT07332975 - No phaseTaking peopleImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Where
- Jacksonville, Phoenix, Rochester
- Age
- 18 years and over
- People
- 324
- Run by
- Mayo Clinic
See details and how to joinNCT06349642 - No phaseTaking peopleRole of the Immune Environment in Response to Therapy in Breast Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 300
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT05396612 - No phaseTaking peopleA Multicenter Cancer Biospecimen Collection Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 1,650
- Run by
- Cofactor Genomics, Inc.
See details and how to joinNCT04510129 - No phaseTaking peopleThe Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
- Where
- Baton Rouge
- Age
- 18 years and over
- People
- 25
- Run by
- Pennington Biomedical Research Center
See details and how to joinNCT06318507 - No phaseTaking peopleCtDNA Based MRD Testing for NAC Monitoring in TNBC
- Where
- Aurora, Houston, Miami Beach, New Orleans, Omaha, Peoria, Salem, Spokane, Stony Brook, St. Petersburg, Tucson, Washington D.C., York, Ypsilanti
- Age
- 18 years and over
- People
- 422
- Run by
- Personalis Inc.
See details and how to joinNCT06230185 - No phaseTaking peopleThe Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
- Where
- Elizabethtown
- Age
- 18 years and over
- People
- 800
- Run by
- VastBiome
See details and how to joinNCT05037825